Literature DB >> 16690497

Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.

Mitsuharu Ueda1, Yukio Ando, Katsuki Haraoka, Shoichi Katsuragi, Yasuhiro Terasaki, Mineharu Sugimoto, Xuguo Sun, Makoto Uchino.   

Abstract

Although aging is closely related with the onset of senile systemic amyloidosis (SSA) caused by wild-type transthyretin (TTR), the effect of aging on amyloid formation has remained unclear in familial amyloidotic polyneuropathy (FAP), caused by variant- and wild-type TTR. The aim of this study was to elucidate the effects of aging and/or other factors in FAP on amyloid formation in the lung, one of the most important target organs of amyloid deposition in SSA. Pulmonary amyloid distribution was determined using 19 autopsied lung samples from patients with FAP amyloidogenic TTR (ATTR) V30M, the most common type of FAP. Amyloid deposition was observed around the walls of the bronchi/ bronchioles, the pulmonary arteries, and the pulmonary veins, while no amyloid deposits could be found around the lymphatics. In addition, amyloid deposition in the alveolar regions was a characteristic finding in aged patients with FAP ATTR V30M (average ages of the patients with amyloid positive vs. negative: 50.55 +/- 8.75 vs. 39.75 +/- 4.17 years old, p < 0.005), similar to the finding in one SSA patient. These results suggest that aging could play an important role in the progression of pulmonary amyloid formation in FAP ATTR V30M.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690497     DOI: 10.1080/13506120500537194

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  6 in total

1.  Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.

Authors:  Jinping Liu; Jie Lan; Peng Zhao; Fang Zheng; Jingjing Song; Peilan Zhang; Xuguo Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  Transbronchial biopsies safely diagnose amyloid lung disease.

Authors:  Praveen Govender; Colleen M Keyes; Elizabeth A Hankinson; Carl J O'Hara; Vaishali Sanchorawala; John L Berk
Journal:  Amyloid       Date:  2017-04-10       Impact factor: 7.141

3.  Hereditary Amyloidosis with Recurrent Lung Infiltrates.

Authors:  Alberto E Revelo; Crischelle Magaspi; George Maguire; Wilbert S Aronow
Journal:  Am J Case Rep       Date:  2016-11-22

4.  Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients.

Authors:  Astrid Monfort; Alexia Rivas; Rishika Banydeen; Jocelyn Inamo; Karim Farid; Remi Neviere
Journal:  Respir Res       Date:  2022-03-27

5.  Wild-type Transthyretin Amyloidosis with Diffuse Alveolar-septal Amyloidosis Diagnosed by a Transbronchial Lung Biopsy.

Authors:  Masaki Ishida; Masamitsu Enomoto; Tae Hata; Tomoki Tanaka; Chikara Sakaguchi; Nobuyo Tamiya; Michiko Tsuchiya; Yukio Nagasaka
Journal:  Intern Med       Date:  2022-07-15       Impact factor: 1.282

Review 6.  Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.

Authors:  Yoshiki Sekijima; Mitsuharu Ueda; Haruki Koike; Sonoko Misawa; Tomonori Ishii; Yukio Ando
Journal:  Orphanet J Rare Dis       Date:  2018-01-17       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.